News

 

Belharra Therapeutics Announces Strategic Collaboration with Sanofi to Advance Discovery of Novel Small Molecule Therapeutics for Immunological Diseases
June 18, 2024
Belharra’s Rachel Lane and Sherry Niessen Featured in Genetic Engineering & Biotechnology Article on Protein-Protein Interactions
March 1, 2024
Belharra CEO Jeff Jonker Talks with Endpoint News About New “Birth of a Biotech” Podcast Series
February 29, 2024
Birth of a Biotech Podcast and Belharra CEO Featured in Fierce Pharma Article
February 29, 2024
Belharra’s Very Own Mike Lazear Listed as one of the 2024 Rising Stars in Proteomics by JPR
January 5, 2024
Belharra Named to the NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
January 3, 2024
Belharra CEO Jeff Jonker Joins Award-winning Biotech Journalist Luke Timmerman on the 150th Episode of The Long Run Podcast
December 13, 2023
Belharra Excited to be Among C&EN’s 10 Start-ups to Watch in 2024
November 10, 2023
Belharra Therapeutics Debuts With $130 Million in Funding
January 4, 2023
Belharra Therapeutics Announces Broad Collaboration with Genentech to Discover and Develop Novel Medicines Across Multiple Therapeutic Areas
January 4, 2023